Clinic
Obiora M Ekweani MD, PA
Obiora M Ekweani MD, PA was paid $639K by Medicaid between Jan 2018 and Dec 2024, across 44 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 35% of everything it billed.
33Billing provider infoOBIORA M EKWEANI MD, PA
FRISCO, TX 75034
FRISCO, TX 75034
33aNPI1013031095assigned 03/16/2007
33bProvider typePrimary Care Clinic/Center
28Total paid$639K
24GClaims42,713
24DCodes billed44
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Primary Care Clinic/Center providers in Texas
Rank by total paid#23 of 180
Median peer was paid$25K
This provider vs. median25×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,356 | $2K | |
| 2019 | 3,659 | $38K | |
| 2020 | 8,894 | $133K | |
| 2021 | 11,041 | $167K | |
| 2022 | 8,667 | $122K | |
| 2023 | 6,922 | $99K | |
| 2024incomplete | 2,174 | $79K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 35% | 6,584 | 5,379 | $226K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 34% | 1,307 | 1,184 | $218K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 5.9% | 904 | 856 | $38K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4.9% | 1,159 | 988 | $31K |
| 99091 | 1.7% | 162 | 144 | $11K | |
| 80053 | Comprehensive metabolic panel | 1.5% | 1,830 | 1,717 | $10K |
| 85027 | 1.4% | 2,529 | 2,342 | $9K | |
| 80061 | Lipid panel | 1.4% | 1,599 | 1,502 | $9K |
| 83735 | 1.4% | 2,415 | 2,250 | $9K | |
| 93000 | 1.3% | 977 | 899 | $8K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.2% | 1,463 | 1,377 | $8K |
| 82977 | 1.0% | 2,413 | 2,248 | $7K |
32 more codes
| 83615 | <1% | 2,414 | $6K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 469 | $5K |
| 82248 | <1% | 2,413 | $5K | |
| 84481 | <1% | 439 | $4K | |
| 84100 | <1% | 2,413 | $4K | |
| 84550 | <1% | 2,411 | $4K | |
| 81002 | <1% | 2,106 | $4K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 82 | $4K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 41 | $3K |
| 95923 | <1% | 67 | $3K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 473 | $3K |
| 84439 | <1% | 441 | $3K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 18 | $1K |
| 81025 | <1% | 199 | $1K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 17 | $947.03 |
| 82044 | <1% | 288 | $840.30 | |
| 93922 | <1% | 155 | $837.44 | |
| 95943 | <1% | 15 | $722.80 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 54 | $639.40 |
| 82570 | <1% | 287 | $550.69 | |
| 99490 | Ccm add 20min | <1% | 72 | $427.07 |
| 87430 | <1% | 19 | $254.16 | |
| 99457 | <1% | 228 | $234.39 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 15 | $226.63 |
| 82150 | <1% | 111 | $195.84 | |
| 82550 | <1% | 111 | $185.98 | |
| 99458 | <1% | 60 | $75.20 | |
| 95921 | <1% | 68 | $69.77 | |
| 96127 | <1% | 1,112 | $8.98 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 61 | $0.00 |
| 99173 | 0% | 29 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 2,683 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialEKWEANI, OBIORA (PRESIDENT)